Pralsetinib

CAT: 0804-HY-112301-01Size: 2 mgDry Ice: NoHazardous: No
CAT#:0804-HY-112301-01Size:2 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Pralsetinib (BLU-667) is a highly potent, selective RET inhibitor. Pralsetinib (BLU-667) inhibits WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET fusion with IC50s of 0.4, 0.3, 0.4, 0.4, and 0.4 nM, respectively[1].
CAS Number
[2097132-94-8]
Product Name Alternative
BLU-667
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Blu667.html
Purity
99.98
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C([C@@]1(OC)CC[C@H](C2=NC(NC3=NNC(C)=C3)=CC(C)=N2)CC1)N[C@H](C4=CC=C(N5N=CC(F)=C5)N=C4)C
Molecular Formula
C27H32FN9O2
Molecular Weight
533.60
Precautions
H302, H315, H319, H335
References & Citations
[1]Subbiah V, et al. Precision Targeted Therapy With BLU-667 for RET-Driven Cancers. American Association for Cancer Research. 10.1158/2159-8290.CD-18-0338.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched

Alternative Products

CatalogName
M22062-01Pralsetinib
MBS3846014-01cis-Pralsetinib
A19526-10Pralsetinib 10mg
MF-0005000Trans-Pralsetinib
A19526-50Pralsetinib 50mg
A19526-1Pralsetinib 1mg
A19526-2Pralsetinib 2mg
A19526-100Pralsetinib 100mg
A19526-5Pralsetinib 5mg
A19526-25Pralsetinib 25mg

Popular Products